U.S.SECURITIES AND EXCHANGE COMMISSION

| x | QUARTERLY      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|---|---------------------------------------------------------------------------------------------------|

|  ̈ | TRANSITION      REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF    1934 |
|--------|---------------------------------------------------------------------------------|

----

----

| Nevada                                                                  |         | 88-0507007                               |
|-------------------------------------------------------------------------|--------------|------------------------------------------|
| (State      or other jurisdiction ofincorporation      or organization) |    | (IRS      Employer IdentificationNumber) |

|   | Large      accelerated filer   ̈ | Accelerated      filer    ̈ |
|--------|------------------------------------------------|------------------------------------------------|
|   | Non-accelerated      filer   ̈   | Smaller      reporting company  x    |

----

ONCOLINTHERAPEUTICS, INC. AND SUBSIDIARIES

| Part      I  | Financial      Information |
|--------------|----------------------------|
|         |                       |   |   |   |
|         | Item      1.               | Financial      Statements |   |   |
|         |                       |   |   |   |
|         |                       | Consolidated      Balance Sheets (unaudited) |   |   |
|         |                       | June      30, 2010 and March 31, 2010 |   | 3 |
|         |                       |   |   |   |
|         |                       | Consolidated      Statements of Operations (unaudited) |   |   |
|         |                       | Three      Months Ended June 30, 2010 and 2009, and |   |   |
|         |                       | Inception      (May 9, 2007) through June 30, 2010 |   | 4 |
|         |                       |   |   |   |
|         |                       | Consolidated      Statements of Cash Flow (unaudited) |   |   |
|         |                       | Three      Months Ended June 30, 2010 and 2009, and |   |   |
|         |                       | Inception      (May 9, 2007) through June 30, 2010 |   | 5 |
|         |                       |   |   |   |
|         |                       | Notes      to Unaudited Consolidated Financial Statements |   | 6 |
|         |                       |   |   |   |
|         | Item      2.               | Management’s      Discussion and Analysis of Financial Condition and Results of      Operations |   | 7 |
|         |                       |   |   |   |
|         | Item      3.               | Quantitative      and Qualitative Disclosures About Market Risk |   | 8 |
|         |                       |   |   |   |
|         | Item      4.               | Controls      and Procedures |   | 8 |
|         |                       |   |   |   |
| Part      II | Other      Information     |   |   |
|         |                       |   |   |   |
|         | Item      5.               | Exhibits |   |   |

----

|                                                                                                                                                                                   |   | June 30, 2010 |       |   | March 31, 2010 |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------|------------|--------|--------------------------|--------|
|                                                                                                                                                                                   |   |                    |       |   |                     |   |
| ASSETS                                                                                                                                                                                 |   |                    |       |   |                     |   |
|                                                                                                                                                                                   |   |                    |       |   |                     |   |
| Cash      and cash equivalents                                                                                                                                                         |   | $                       | 14         |   |                     | $      | 14 |   |
| Total      current assets                                                                                                                                                              |   |                    | 14         |   |                     |   | 14 |   |
| Property      and equipment, net                                                                                                                                                       |   |                    | 2,071      |   |                     |   | 2,286 |   |
| Total      assets                                                                                                                                                                      |   | $                       | 2,085      |   |                     |   | 2,300 |   |
|                                                                                                                                                                                   |   |                    |       |   |                     |   |   |   |
| LIABILITIES      AND SHAREHOLDERS' DEFICIT                                                                                                                                             |   |                    |       |   |                     |   |   |   |
|                                                                                                                                                                                   |   |                    |       |   |                     |   |   |   |
| Current      liabilities:                                                                                                                                                              |   |                    |       |   |                     |   |   |   |
| Accounts      payable                                                                                                                                                                  |   | $                       | 227,480    |   |                     | $      | 222,460 |   |
| Accounts      payable – related parties                                                                                                                                          |   |                    | 144,122    |   |                     |   | 144,122 |   |
| Accrued      liabilities                                                                                                                                                               |   |                    | 40,751     |   |                     |   | 37,600 |   |
| Convertible      notes payable – related parties                                                                                                                                 |   |                    | 63,302     |   |                     |   | - |   |
| Notes      payable – related parties                                                                                                                                             |   |                    | 42,278     |   |                     |   | 99,478 |   |
| Total      current liabilities                                                                                                                                                         |   |                    | 517,933    |   |                     |   | 503,660 |   |
|                                                                                                                                                                                   |   |                    |       |   |                     |   |   |   |
| Shareholders      deficit:                                                                                                                                                             |   |                    |       |   |                     |   |   |   |
| Common      stock, $.001 par value, 500,000,000 shares authorized; 23,682,763 and      23,182,763 shares issued and outstanding at June 30, 2010 and March 31,      2010, respectively |   |                    | 23,683     |   |                     |   | 23,183 |   |
| Additional      paid-in capital                                                                                                                                                        |   |                    | 2,360,714  |   |                     |   | 2,321,214 |   |
| Deficit      accumulated during the development stage                                                                                                                                  |   |                    | (2,900,245 | )      |                     |   | (2,845,757 | ) |
| Total      shareholders’ deficit                                                                                                                                                 |   |                    | (515,848   | )      |                     |   | (501,360 | ) |
| Total      liabilities and shareholders' deficit                                                                                                                                       |   | $                       | 2,085      |   |                     | $      | 2,300 |   |

----

|                                                                               |   | Three Months Ended June 30, |       |   | Inception (May 9,2007) to |   |
|------------------------------------------------------------------------------------|--------|-------------------------------------------------|------------|--------|------------------------------------------|--------|
|                                                                               |   | 2010                                            |       |   | 2009                                     |   |   | June 30, 2010 |   |
|                                                                               |   |                                            |       |   |                                     |   |   |   |   |
| Revenue                                                                            |   | $                                               | -          |   |                                     | $      | - |   |   | $ | - |   |
|                                                                               |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Costs      and expenses:                                                           |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Compensation      and related expenses                                             |   |                                            | 40,000     |   |                                     |   | - |   |   |   | 1,055,724 |   |
| Office      administration                                                         |   |                                            | 4,463      |   |                                     |   | 65 |   |   |   | 25,533 |   |
| Professional      fees                                                             |   |                                            | 6,659      |   |                                     |   | 3,450 |   |   |   | 899,290 |   |
| Investor      relations                                                            |   |                                            | -          |   |                                     |   | - |   |   |   | 292,444 |   |
| Merger      expenses                                                               |   |                                            | -          |   |                                     |   | - |   |   |   | 8,113 |   |
| Impairment      of license agreement                                               |   |                                            | -          |   |                                     |   | - |   |   |   | 80,100 |   |
| Acquisition      costs of subsidiary                                               |   |                                            | -          |   |                                     |   | - |   |   |   | 220,000 |   |
| Depreciation      and amortization                                                 |   |                                            | 215        |   |                                     |   | 257 |   |   |   | 31,963 |   |
| Other      expenses                                                                |   |                                            | -          |   |                                     |   | - |   |   |   | 292,026 |   |
| Total      costs and expenses                                                      |   |                                            | 51,337     |   |                                     |   | 3,772 |   |   |   | 2,905,193 |   |
|                                                                               |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Interest      expense                                                              |   |                                            | 3,151      |   |                                     |   | 2,376 |   |   |   | 473,817 |   |
| Gain      on deconsolidated subsidiary                                             |   |                                            | -          |   |                                     |   | - |   |   |   | (478,765 | ) |
| Net      loss                                                                      |   | $                                               | (54,488    | )      |                                     | $      | (6,148 | ) |   | $ | (2,900,245 | ) |
|                                                                               |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Net      loss per share:                                                           |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Basic      and diluted                                                             |   | $                                               | (0.00      | )      |                                     | $      | (0.00 | ) |   |   |   |   |
|                                                                               |   |                                            |       |   |                                     |   |   |   |   |   |   |   |
| Weighted      average number of common shares outstanding - Basic and      diluted |   |                                            | 23,561,884 |   |                                     |   | 23,102,763 |   |   |   |   |   |

----

|                                                                        |   | Three Months Ended June 30, |    |   | Cumulativefrom Inception(May 9, 2007)through June |   |
|-----------------------------------------------------------------------------|--------|-------------------------------------------------|---------|--------|-----------------------------------------------------------------------|--------|
|                                                                        |   | 2010                                            |    |   | 2009                                                                  |   |   | 30, 2010 |   |
| Cash      flows from operating activities:                                  |   |                                            |    |   |                                                                  |   |   |   |   |
| Net      income (loss)                                                      |   | $                                               | (54,488 | )      |                                                                  | $      | (6,148 | ) |   | $ | (2,900,245 | ) |
| Adjustments      to reconcile net loss to cash used in operatingactivities: |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Depreciation      and amortization                                          |   |                                            | 215     |   |                                                                  |   | 257 |   |   |   | 23,074 |   |
| Amortization      of deferred financing costs                               |   |                                            | -       |   |                                                                  |   | - |   |   |   | 15,000 |   |
| Non-cash      compensation expense relating to license agreement            |   |                                            | -       |   |                                                                  |   | - |   |   |   | 119,900 |   |
| Impairment      of license agreement                                        |   |                                            | -       |   |                                                                  |   | - |   |   |   | 80,100 |   |
| Amortization      of debt discount                                          |   |                                            | -       |   |                                                                  |   | - |   |   |   | 397,985 |   |
| Share-based      compensation                                               |   |                                            | 40,000  |   |                                                                  |   | - |   |   |   | 959,881 |   |
| Non-cash      acquisition of subsidiary                                     |   |                                            | -  |   |                                                                  |   | -  |   |   |   | 220,000 |   |
| Changes      in assets and liabilities:                                     |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Other      current assets                                                   |   |                                            | -  |   |                                                                  |   | -  |   |   |   | 15,750 |   |
| Accounts      payable                                                       |   |                                            | 5,020   |   |                                                                  |   | (947 | ) |   |   | 307,282 |   |
| Accounts      payable – related parties                               |   |                                            | -       |   |                                                                  |   | - |   |   |   | 127,622 |   |
| Accrued      liabilities                                                    |   |                                            | 3,151   |   |                                                                  |   | 2,376 |   |   |   | 77,319 |   |
| Net      cash used in operating activities                                  |   |                                            | (6,102  | )      |                                                                  |   | (4,462 | ) |   |   | (556,332 | ) |
| Cash      flows from investing activities:                                  |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Investment      in option agreement                                         |   |                                            | -       |   |                                                                  |   | - |   |   |   | (20,000 | ) |
| Property      and equipment                                                 |   |                                            | -       |   |                                                                  |   | - |   |   |   | (5,145 | ) |
| Net      cash used in investing activities                                  |   |                                            | -       |   |                                                                  |   | - |   |   |   | (25,145 | ) |
| Cash      flows from financing activities:                                  |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Proceeds      from notes payable – related parties                    |   |                                            | 6,102   |   |                                                                  |   | 4,176 |   |   |   | 233,278 |   |
| Repayment      of notes payable – related party                       |   |                                            | -       |   |                                                                  |   | - |   |   |   | (13,000 | ) |
| Proceeds      from issuance of  common stock                      |   |                                            | -       |   |                                                                  |   | - |   |   |   | 91,165 |   |
| Proceeds      from exercise of stock options                                |   |                                            | -       |   |                                                                  |   | - |   |   |   | 270,048 |   |
| Net      cash provided by financing activities                              |   |                                            | 6,102   |   |                                                                  |   | 4,176 |   |   |   | 581,491 |   |
| Net      change in cash                                                |   |                                            | -       |   |                                                                  |   | (286 | ) |   |   | 14 |   |
| Cash      and cash equivalents, beginning of period                         |   |                                            | 14      |   |                                                                  |   | 300 |   |   |   | - |   |
| Cash      and cash equivalents, end of period                               |   | $                                               | 14      |   |                                                                  | $      | 14 |   |   | $ | 14 |   |
|                                                                        |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Supplemental      disclosures:                                              |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Interest      paid                                                          |   | $                                               | -       |   |                                                                  | $      | - |   |   | $ | 5,633 |   |
| Income      taxes paid                                                      |   | $                                               | -       |   |                                                                  | $      | - |   |   | $ | - |   |
|                                                                        |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Non-cash      financing activities:                                         |   |                                            |    |   |                                                                  |   |   |   |   |   |   |   |
| Discount      on convertible notes                                          |   | $                                               | -       |   |                                                                  | $      | - |   |   | $ | 397,985 |   |
| Cancellation      of stock certificate                                      |   |                                            | -       |   |                                                                  |   | - |   |   |   | 300 |   |
| Issuance      of note payable for license agreement                         |   |                                            | -       |   |                                                                  |   | - |   |   |   | 200,000 |   |
| Stock      issued for prepaid investor relation services                    |   |                                            | -       |   |                                                                  |   | - |   |   |   | 73,800 |   |
| Conversion      of notes payable to common stock                            |   |                                            | -       |   |                                                                  |   | - |   |   |   | 414,568 |   |
| Convertible      note payable issued to extinguish note payable             |   |                                            | 63,302  |   |                                                                  |   | - |   |   |   | 63,302 |   |

----

----

| ITEM      2. | MANAGEMENTS      DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF      OPERATIONS |
|--------------|------------------------------------------------------------------------------------------------|

----

| ITEM      3. | QUANTITATIVE      AND QUALITATIVE DISCLOSURES ABOUT MARKETRISK |
|--------------|----------------------------------------------------------------|

| ITEM      4. | CONTROLS      AND PROCEDURES |
|--------------|------------------------------|

|   | (a) | Evaluation      of Disclosure Controls andProcedures |
|--------|-----|------------------------------------------------------|

|   | (b) | Changes      in Internal Controls Over FinancialReporting |
|--------|-----|-----------------------------------------------------------|

----

| Exhibit No. |   | Description                                                                 |
|------------------|--------|-----------------------------------------------------------------------------|
|             |   |                                                                        |
| 31.1             |   | Certification      of J. Leonard Ivins.                                     |
| 32.1             |   | Certification      for Sarbanes-Oxley Act of J. Leonard  Ivins.   |

----